Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-07

Clinical Trial Update: Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating goserelin (Zoladex) to prevent chemotherapy-induced early menopause in premenopausal women with stage I-III breast cancer; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoladex (goserelin)

Snippet

Sponsor: Anglo Celtic Cooperative Oncology Group | Conditions: Breast Cancer, Infertility | Phase 3 | Status: COMPLETED